Hellman Jordan Management Company’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History
Bought
Maintained
Sold
Other funds holding LABU
IA
FLAM
AIP
SW
RCM
Hellman Jordan Management Company's LABU Position: Q3 2022 in Review
Hellman Jordan Management Company sold out of Direxion Daily S&P Biotech Bull 3X ETF (LABU) in Q3 2022, closing a stake of 1,000 shares — an estimated $135K sold.
Hellman Jordan Management Company first reported a position in LABU in Q2 2016 and held it in 22 quarters. The position peaked at $10.2M in Q3 2018. 47 funds tracked by Wall St. Rank hold LABU as of Q3 2022.
- Hellman Jordan Management Company reported no remaining Direxion Daily S&P Biotech Bull 3X ETF position as of Q3 2022 after selling out during the quarter.
- Hellman Jordan Management Company sold 1,000 Direxion Daily S&P Biotech Bull 3X ETF shares in Q3 2022, an estimated $135K.
- Hellman Jordan Management Company first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q2 2016 and held it in 22 quarters.
- Hellman Jordan Management Company's Direxion Daily S&P Biotech Bull 3X ETF position peaked at $10.2M in Q3 2018.
- 47 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q3 2022.
Based on Hellman Jordan Management Company's 13F filing for Q3 2022, filed 13 Oct 2022.